Register
Login:
Share:
Email Facebook Twitter




SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.26Bid: 0.25Ask: 0.27Change: 0.035 (+15.56%)Riser - Sareum
Spread: 0.02Spread as %: 8.00%Open: 0.225High: 0.285Low: 0.225Yesterday’s Close: 0.225


Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


scoopy
Posts: 901
Off Topic
Opinion:No Opinion
Price:0.53
why
10 Nov '14
very odd, looks like we have some MM games going on?
 
wintzy
Posts: 297
Off Topic
Opinion:No Opinion
Price:0.53
Why?
10 Nov '14
still no buyers but +17%
scoopy
Posts: 901
Off Topic
Opinion:No Opinion
Price:0.53
why
10 Nov '14
what we waiting for! why is there no buys yet?
buzzlightyear4
Posts: 6,305
Off Topic
Opinion:No Opinion
Price:0.43
Very good news
10 Nov '14
Back to .60-.70
Loopylo
Posts: 76
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.43
Good news
10 Nov '14
The more patents the merrier..!!

Presumably it will now crash though.?
PCS1954
Posts: 1,046
Off Topic
Opinion:No Opinion
Price:0.43
View Thread (4)
RE: SAR
7 Nov '14
over 7.5m buys against 0.95m sells is the tide turning??? with or without a CCO!!
Hopkirk
Posts: 1,299
Off Topic
Opinion:No Opinion
Price:0.43
View Thread (4)
RE: SAR
7 Nov '14
Hi PCS. Still here but not much is happening.

The wait continues. ..
PCS1954
Posts: 1,046
Off Topic
Opinion:No Opinion
Price:0.43
View Thread (4)
RE: SAR
7 Nov '14
Hi Hopkirk
Good to see you're still around and glad to see we have a similar view on current status!
GLA
Hopkirk
Posts: 1,299
Off Topic
Opinion:No Opinion
Price:0.43
View Thread (4)
SAR
7 Nov '14
Some nice buying today and now at full ask.

SAR don't have a commercial officer because they don't need one - IMO. CHK1 is being handled by CRUK (who know a thing or two about doing deals) and Aurora is being dealt with by HMU at no cost to SAR. Both are progressing and if I was a big pharma looking to deal, it makes financial sense at this point to wait and see how they progress. Yes, they will pay more by dealing at a later stage, but there will be less risk of paying for something that doesn't get to clinical trials and is therefore worthless.

If either does get that far (a fair assumption based on the last RNS) then becomes a known gamble. Even the largest pharma have failures (research AZD7762 to see how AstraZenica failed after years or research, spending millions on CHK1) but the measurable failure rates become known as all trials are logged and monitored. Before trials start, the information regarding success or failure rates is a bit sketchy.

GLA
Num4
Posts: 601
Off Topic
Opinion:No Opinion
Price:0.43
Patrick
6 Nov '14
Patrick was involved with the CRT BACIT partnership.
His track record is positive and a good colleague to have on speed dial.





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.